What smart money is saying about Bioventus Inc.
BVS
No fund has written a full thesis on Bioventus Inc. in our archive, but 1 fund letter reports a position in it, most recently Brown Advisory Small-Cap Growth Strategy in September 2026.
Get an email when a fund buys, sells or pitches it
1
Reported positions
1
Bought
0
Sold
1
Letter
Position history
Every position in Bioventus Inc. on record in the archive was reported in Q3 2026, across 1 fund letter, with 1 buy (opened or added).
| Quarter | Letters | Bought | Sold | Theses |
|---|---|---|---|---|
| Q3 2026 | 1 | 1 | 0 | 0 |
Bought and Sold count moves: the same sentence published by several funds of one house in a quarter counts once.
Fund activity · 1 position · 1 move
- New positionBrown Advisory Small-Cap Growth StrategySeptember 2026
“Bioventus, Inc. Class A (BVS) is a niche medical technology company focused on musculoskeletal pain relief and active healing, with products that help improve recovery, restore mobility, and provide non-opioid alternatives to pain management.”
Bioventus Inc.
Read the letters behind these Bioventus Inc. positions
Every quote above comes from a fund letter in our archive. Get unlimited access to the letters themselves, and to Warren AI, which reads all of them for you.
View plans→Share this ledger